Wildgen provides Biotech Venture Lounge winner with comprehensive package
SeaLife Pharma, an Austrian drug manufacturer, was named ‘Best start-up from the Biotech sector’ at the Biotech Venture Lounge and received a comprehensive package from Wildgen.
The Biotech Venture Lounge took place on 30 April 2014 in Luxembourg and was sponsored by Wildgen and the Luxembourg Privare Equity and Venture Capital Association (LPEA). Visitors were able to hear speeches and attend expert lectures.
ALRISE Biosystems and Amakem Therapeutics also won awards.
News from Wildgen
Briefings from Wildgen
The Luxembourg District Court sitting in commercial matters has rejected the applications of ESI and RIO FORTE to be placed under controlled management.
The Luxembourg District Court sitting in commercial matters has declared bankrupt the companies ESFG and ESFIL.